-
Mashup Score: 92Bishoy Faltas, MD, Named Chief Research Officer of the Englander Institute for Precision Medicine at Weill Cornell Medicine - 14 hour(s) ago
Olivier Elemento, PhD, Director of the Englander Institute for Precision Medicine (EIPM) at Weill Cornell Medicine, New York, recently announced that Bishoy M. Faltas, MD, has been named Chief Researc…
Source: ascopost.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 1
In this episode of Bladder Cancer Matters, Rick Bangs talks Dr. Bishoy Faltas about the promise of artificial intelligence in bladder cancer.
Source: bcan.orgCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 3
Abstract. The intersection of precision medicine and artificial intelligence (AI) holds profound implications for cancer treatment, with the potential to significantly advance our understanding of drug responses based on the intricate architecture of tumor cells. A recent study by Park and colleagues titled
Source: aacrjournals.orgCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 7BPoD | Remote Control - 2 month(s) ago
BPoD (Biomedical Picture of the Day) is a free educational resource showcasing biomedical imagery. Managed by the MRC Laboratory of Medical Sciences the website aims to engage the general public. Images are provided for inclusion on this website through the generosity of scientists across the globe.
Source: bpod.org.ukCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 249The evolution of metastatic upper tract urothelial carcinoma through genomic-transcriptomic and single-cell protein markers analysis - 2 month(s) ago
Nature Communications – Detailed molecular studies are required to understand the differences between primary and metastatic upper tract urothelial carcinoma (UTUC). Here, the authors use genomics,…
Source: www.nature.comCategories: General Medicine News, Hem/OncsTweet-
Excited to share our new paper just published @NatureComms @WCMGUcancer @WeillCornell https://t.co/QPjilU9FHe Great collaboration between my lab with @ElementoLab @WCMEnglanderIPM and J.M. Mosquera @WCMCPathology 🔬 Full tweetorial below with more updates to come. Stay tuned! https://t.co/4vprHXnGZu https://t.co/BesBxiGzT5
-
-
Mashup Score: 247The evolution of metastatic upper tract urothelial carcinoma through genomic-transcriptomic and single-cell protein markers analysis - 2 month(s) ago
Nature Communications – Detailed molecular studies are required to understand the differences between primary and metastatic upper tract urothelial carcinoma (UTUC). Here, the authors use genomics,…
Source: www.nature.comCategories: General Medicine News, Hem/OncsTweet-
Excited to share our new paper just published @NatureComms @WCMGUcancer @WeillCornell https://t.co/QPjilU9FHe Great collaboration between my lab with @ElementoLab @WCMEnglanderIPM and J.M. Mosquera @WCMCPathology 🔬 Full tweetorial below with more updates to come. Stay tuned! https://t.co/4vprHXnGZu https://t.co/BesBxiGzT5
-
-
Mashup Score: 244The evolution of metastatic upper tract urothelial carcinoma through genomic-transcriptomic and single-cell protein markers analysis - 2 month(s) ago
Nature Communications – Detailed molecular studies are required to understand the differences between primary and metastatic upper tract urothelial carcinoma (UTUC). Here, the authors use genomics,…
Source: www.nature.comCategories: General Medicine News, Hem/OncsTweet-
Excited to share our new paper just published @NatureComms @WCMGUcancer @WeillCornell https://t.co/QPjilU9FHe Great collaboration between my lab with @ElementoLab @WCMEnglanderIPM and J.M. Mosquera @WCMCPathology 🔬 Full tweetorial below with more updates to come. Stay tuned! https://t.co/4vprHXnGZu https://t.co/BesBxiGzT5
-
-
Mashup Score: 242The evolution of metastatic upper tract urothelial carcinoma through genomic-transcriptomic and single-cell protein markers analysis - 2 month(s) ago
Nature Communications – Detailed molecular studies are required to understand the differences between primary and metastatic upper tract urothelial carcinoma (UTUC). Here, the authors use genomics,…
Source: www.nature.comCategories: General Medicine News, Hem/OncsTweet-
Excited to share our new paper just published @NatureComms @WCMGUcancer @WeillCornell https://t.co/QPjilU9FHe Great collaboration between my lab with @ElementoLab @WCMEnglanderIPM and J.M. Mosquera @WCMCPathology 🔬 Full tweetorial below with more updates to come. Stay tuned! https://t.co/4vprHXnGZu https://t.co/BesBxiGzT5
-
-
Mashup Score: 242The evolution of metastatic upper tract urothelial carcinoma through genomic-transcriptomic and single-cell protein markers analysis - 2 month(s) ago
Nature Communications – Detailed molecular studies are required to understand the differences between primary and metastatic upper tract urothelial carcinoma (UTUC). Here, the authors use genomics,…
Source: www.nature.comCategories: General Medicine News, Hem/OncsTweet-
Excited to share our new paper just published @NatureComms @WCMGUcancer @WeillCornell https://t.co/QPjilU9FHe Great collaboration between my lab with @ElementoLab @WCMEnglanderIPM and J.M. Mosquera @WCMCPathology 🔬 Full tweetorial below with more updates to come. Stay tuned! https://t.co/4vprHXnGZu https://t.co/BesBxiGzT5
-
-
Mashup Score: 61
Dr. Bishoy M. Faltas was awarded the grant to advance his research into the role of APOBEC3 enzymes in advanced bladder cancer.
Source: www.nyp.orgCategories: General Medicine News, Hem/OncsTweet
Bishoy Faltas, MD, Named Chief Research Officer of the Englander Institute for Precision Medicine at Weill Cornell Medicine - The ASCO Post https://t.co/0K5t9s2g43